Skip to main content
SRRK logo

SRRK · Scholar Rock Holding Corp · Metrics

Track SRRK — free
$41.54 +1.30 (+3.23%)
Market Cap
$4.90B
Shares
121.79M
Volume · Oct 20 829.21K Avg daily vol (3M) 1.59M

SRRK metrics

72 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$40.24
Market cap
$4.90B

Price action

20 metrics
Price change (1W)
-4.1%
Price change (30D)
-16.4%
Price change (3M)
-20.6%
Price change (6M)
-15.8%
Price change (YTD)
-8.6%
Price change (1Y)
+44.0%
Trailing year
Price change (5Y)
+51.8%
52-week high
$60.04
52-week low
$27.92
Change from 52-week high
-33.0%
Change from 52-week low
+44.1%
Annualized volatility
55.7%
Annualized volatility (3M)
48.5%
Beta
1.1
RSI (14D)
30.2
Price vs SMA 50
-20.2%
Price vs SMA 200
-16.6%
Avg volume (3M)
1.59M
Relative volume
0.9
Average dollar volume
$78.47M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
121.79M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
19.1
reciprocal yield 5.2%
FCF yield
-6.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
32.1×
reciprocal yield 3.1%
EV / revenue historical average (5Y)
32.1×
reciprocal yield 3.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$406.36M
Net income (TTM)
−$408.59M
Trailing 12 months
Diluted EPS (TTM)
$-3.31
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-3.31
EBITDA per diluted share (TTM)
$-3.30
Net income per diluted share (TTM)
$-3.32
Operating cash flow per diluted share (TTM)
$-2.42
Free cash flow per diluted share (TTM)
$-2.42
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$1.69
Stock compensation per diluted share (TTM)
$0.62
Book value per share
$2.26

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+15.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-161.0%
Return on assets
-78.0%
Debt / equity
0.8
Current ratio
7.0
EBITDA (TTM)
−$404.88M
Free cash flow (TTM)
−$297.01M
Quick ratio
7.0
Interest coverage
-38.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$295.88M
Latest balance sheet
Cash & equivalents
$437.09M
Total assets
$523.54M
Total debt
$196.20M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$296.83M
Capital expenditures (TTM)
$185,000
R&D (TTM)
$207.41M
SG&A (TTM)
—
Stock compensation (TTM)
$75.66M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
310
13F filer change QoQ
+29
Institutional ownership
114.4%
Conviction holders (share of 13F filers)
1.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.6%
Holder tenure
13.0
Price vs estimated holder cost
+56.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.6%

Short interest

3 metrics
Short interest
18.7%
Latest settlement · 9.3 days to cover
Days to cover
9.3d
Short-squeeze score
79 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1727196 CUSIP 80706P103 13F (30d) 16 filings 16 filers Visit website Investor relations